AKT1 and cancer: Although it has been stated that it is unclear how AKT may be stimulated in cancer cells in the setting of radiation so that radioresistance is generated [2], we would point out that physiological levels of thyroid hormone as T4 activate the AKT pathway via the cell surface thyroid hormone receptor on integrin αvβ3 [20, 21].